Pharmaceutical Market Europe • November 2021 • 5
CONTENTS
NEWS & COLUMNS
6-7 NEWS
UK government pledges £5bn for health R&D; UK’s MHRA approves first oral antiviral against COVID-19
8-9 NEWS
Pfizer’s 2021 revenue predictions soar to $82bn; Gilead's Q3 sales buoyed by anti-COVID-19 drug
10-11 CORONAVIRUS NEWS
Pfizer/BioNTech's booster jab gives 95.6% efficacy; Valneva's COVID-19 vaccine more effective than AZ's
12 DARWIN'S MEDICINE
Aduhelm's two futures – it either has a future or it doesn't
13 POLICY AND PUBLIC HEALTH
We're following the science – a loaded phrase if ever there was one
14 EVERY LITTLE HELPS
Every little helps in the fight to combat climate change
15 PHARMA MARKETERS' BLOG
Segmentation – are we missing the mark?
FEATURES
16-17 DIGITAL INNOVATION: SUPPORTING PATIENTS WITH CHRONIC DISEASES
Helping our healthcare systems support people with multiple chronic conditions and give them a more holistic view, improving medical outcomes and efficiency
18-20 EXTENDING AND ENRICHING THE LIFE CYCLE OF CLINICAL TRIAL DATA
As digital transformation is achieved in life sciences, data will play a central and multifaceted role in innovation and in streamlining the development of new therapies at lower cost
24-25 PANDEMIC-ERA REAL- WORLD DATA ANALYSIS
Looking at best practices and how researchers should approach this analysis – real-world evidence studies that include data collected during this period are valuable to their research
28 BOOK NEWS – ROHIT KHANNA
Misunderstanding health – America’s healthcare
COMMUNIQUE
MARKETING & COMMS
30-31 ACHIEVING CONNECTED TEAMWORK FOR PATIENTS AND HCPS
Achieving better results for patients and HCPs – the advent of digital health solutions is transforming how healthcare takes place, giving patients the chance to receive truly bespoke care that matches precise individual needs
32-33 CORPORATE SOCIAL RESPONSIBILITY: A CULTURE, NOT A BRANDING BADGE
Companies’ actions have significant impact on people’s lives in terms of the products and services they offer and the jobs and opportunities they create
34-35 IT’S TIME TO BE BRAVE AND EMBRACE DISRUPTION
Putting patients and HCPs at the heart of crafting healthcare improvements – to build an emotional connection, brands need to position HCPs and patients as key influencers
42 PEOPLE
Q&A with Rohit Khanna
CAREERS & RECRUITMENT
38-40 APPOINTMENTS
Changes at the EMG, Alnylam and Amylyx
43 PHARMA MARKETING JOBS
Jobs in pharma marketing, sales and communications